CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 276 enrolled
Drug / intervention
Ahmed implant +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00376363
NCT00376363N/ACompleted
CompareCT.gov

Ahmed Versus Baerveldt Comparison Study

University of Miami·interventional·Posted Sep 14, 2006·Updated Aug 20, 2015

In Brief

A clinical study evaluating Ahmed implant and Baerveldt implant for Glaucoma. Completed, enrolled 276 participants across 1 site.

Detailed Summary

The objective of this study is to compare the long-term safety and efficacy of the Ahmed and the Baerveldt implants in patients who are undergoing aqueous shunt implant surgery for glaucoma. One eye of eligible patients will be randomized. Outcome measures include intraocular pressure, visual acuity, visual field, number of glaucoma medications, glaucoma reoperations, and complications, including suprachoroidal hemorrhage, endophthalmitis, choroidal effusion, diplopia, corneal edema, and shunt/tube erosion.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesUnited States
CollaboratorsNational Eye Institute (NEI), Research to Prevent Blindness

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 14, 2006
Enrollment StartNov 1, 2005
Primary CompletionDec 1, 2013
Study CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 8.1 yearsPosted 19.8 years ago

Interventions

Ahmed implantdevice

placement of glaucoma drainage device to control intraocular pressure

Baerveldt implantdevice

placement of glaucoma drainage device to control intraocular press